Ori Gutwerg is VP at ANI PHARMACEUTICALS INC (ANIP). They have made 8 open-market trades across 1 company since 2023, most recently 2026-08-10.
CIK 0001846478
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ANIP | 75,534 | $5.5M |
Shares reported on the most recent Form 4, priced at the 2026-08-11 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ANIP | SELL | 2026-08-10 | 2026-08-11 | $77.00 | $243K | +1.9% | -3.5% | — |
| ANIP | SELL | 2026-05-12 | 2026-05-13 | $79.50 | $220K | -0.3% | -0.0% | -8.5% |
| ANIP | SELL | 2026-03-03 | 2026-03-04 | $76.50 | $158K | -4.5% | +2.1% | -1.2% |
| ANIP | SELL | 2025-08-12 | 2025-08-14 | $86.53 | $1.0M | +3.9% | +11.7% | -1.4% |
| ANIP | SELL | 2025-05-15 | 2025-05-16 | $60.07 | $106K | -2.1% | +8.0% | +51.2% |
| ANIP | SELL | 2025-03-05 | 2025-03-07 | $60.00 | $323K | +8.2% | +11.7% | -0.2% |
| ANIP | SELL | 2024-06-05 | 2024-06-06 | $67.00 | $200K | -11.4% | -9.0% | -8.2% |
| ANIP | SELL | 2023-08-23 | 2023-08-25 | $62.39 | $1.9M | -2.4% | -9.4% | -19.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.